Jürgen Gotz

Professor Jürgen Gotz is a leading academic at the Queensland Brain Institute (QBI) of the University of Queensland, currently serving as the Lesleigh Green - Bill and Nancy Green Chair in Dementia Research and Director of QBI’s Clem Jones Centre for Ageing Dementia Research. His pioneering work focuses on innovative treatments for Alzheimer’s disease, including ultrasound therapy and Tau-targeting antibodies.

• Role: Director, Clem Jones Centre for Ageing Dementia Research
• Key Research Themes: Alzheimer’s disease, neurodegenerative disorders, immunotherapy, non-invasive treatments
• Major Grants: $3.2 million NHMRC Ideas Grant (2023), $2.7 million ARC Discovery Project funding (2023), $6 million for NHMRC Centres of Research Excellence (2024)

Research Overview: Gotz’s work explores how focused ultrasound and immunotherapeutic antibodies can restore brain function in neurodegenerative diseases. His team’s findings challenge traditional approaches, such as demonstrating that amyloid plaque targeting is not essential for cognitive improvement in ultrasound therapy (2024) and developing novel Tau antibodies to address protein dysregulation (2024).

Collaborative Efforts: Collaborations with researchers like Dr. Pranesh Padmanabhan highlight his interdisciplinary approach, combining neuroscience, biomedical engineering, and clinical research to translate discoveries into patient-focused solutions.

• Scientific Recognition: Finalist in the 2023 Research Australia Awards for his Queensland-made ultrasound device.